The second strategy includes active immunisation, where antigen presenting cells (APCs) are loaded with TAA to induce full-blown anti-tumor responses that consist of effective CD4+ and CD8+ T-cell responses and prolonged memory [4-6]. The gene discussed is CD8A; the disease is neoplasm.